Image (1a59ceb2 1cf8 4871 85d6 518fbe49dfef 183 1)
Amlodipine Besylate Tablet
Product Images NDC 68788-4082
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 68788-4082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Amlodipine Besylate (63bc4df8 5e26 45dd 8a05 78ee94553129 01)
Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)
This is not available.*
Amlodipine Besylate Tablets Usp 2.5mg (63bc4df8 5e26 45dd 8a05 78ee94553129 04)
This text provides information regarding Amlodipine Besylate Tablets USP2, a generic version of Norvasc. It includes details about the tablet strength, dosage, storage instructions, warnings, manufacturer (Lupin Limited), and prescription details. It emphasizes the importance of not transferring the drug to anyone other than the patient for whom it was prescribed. Additionally, it outlines precautions such as storing the medication at controlled room temperature, protecting it from light and moisture, and keeping it out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
